Sinopharm
1099.HK
#2606
Rank
โ‚น636.91 B
Marketcap
โ‚น204.10
Share price
-0.58%
Change (1 day)
-10.77%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Revenue for Sinopharm (1099.HK)

Revenue in 2025: โ‚น7.721 Trillion

According to Sinopharm's latest financial reports the company's current revenue (TTM ) is โ‚น7.721 Trillion. In 2025 the company made a revenue of โ‚น7.721 Trillion an increase over the revenue in the year 2024 that were of โ‚น7.521 Trillion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sinopharm from 2006 to 2025

Annual revenue

Year Revenue Change
2025โ‚น7.721 T2.65%
2024โ‚น7.521 T-5.1%
2023โ‚น7.926 T5.42%
2022โ‚น7.518 T-2.1%
2021โ‚น7.679 T16.85%
2020โ‚น6.572 T14.95%
2019โ‚น5.717 T21.52%
2018โ‚น4.704 T5.93%
2017โ‚น4.441 T27.22%
2016โ‚น3.491 T5.37%
2015โ‚น3.313 T9.14%
2014โ‚น3.035 T17.22%
2013โ‚น2.589 T25.94%
2012โ‚น2.056 T34.61%
2011โ‚น1.527 T55.34%
2010โ‚น983.34 B35.79%
2009โ‚น724.17 B37.56%
2008โ‚น526.45 B31.43%
2007โ‚น400.57 B40.26%
2006โ‚น285.58 B